UPDATED Aug 28, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ERIS | ₹1,792.50 | 2.3% | 33.5% | ₹244.2b | ₹1,860.10 | PE63.2x | E31.4% | 0.4% | ||
SPRO | US$2.00 | 7.5% | 46.0% | US$111.4m | US$4.00 | PS2.3x | E31.4% | n/a | ||
4587 | JP¥1,523.50 | 0.5% | -39.8% | JP¥197.3b | JP¥3,414.29 | PS10.3x | E31.4% | n/a | ||
TEVA | US$18.04 | -4.0% | -3.7% | US$20.7b | US$23.56 | PS1.2x | E31.1% | 0% | ||
CRON | CA$3.57 | 0.6% | 20.2% | CA$1.4b | CA$3.63 | PE53.8x | E31.1% | n/a | ||
RVU | zł29.20 | -2.5% | -45.4% | zł675.1m | zł44.60 | PS6.9x | E30.9% | n/a | ||
INNOVACAP | ₹902.40 | 0.2% | 38.6% | ₹51.6b | ₹1,076.00 | PE39.8x | E30.6% | n/a | ||
HOTH | US$1.21 | -6.2% | 72.9% | US$16.0m | US$5.00 | PB1.6x | E30.6% | n/a | ||
300841 | CN¥76.32 | -11.5% | 46.9% | CN¥9.7b | CN¥64.00 | PE35.9x | E30.3% | 1.3% | ||
XFOR | US$4.12 | 29.6% | -80.2% | US$95.0m | US$23.25 | PS2.8x | E30.3% | n/a | ||
688176 | CN¥11.48 | -5.0% | 128.2% | CN¥6.5b | CN¥10.30 | PS27.1x | E30.2% | n/a | ||
NAMS | US$23.95 | -2.0% | 48.8% | US$2.8b | US$40.27 | PS42.1x | E30.0% | n/a | ||
688278 | CN¥82.73 | -4.0% | 47.3% | CN¥33.7b | CN¥76.00 | PE35.4x | E30.0% | 0.7% | ||
OCUL | US$12.52 | 3.2% | 46.3% | US$2.1b | US$17.45 | PS38.4x | E29.9% | n/a | ||
MBRX | US$0.39 | -34.1% | -84.5% | US$18.4m | US$7.00 | PE-0.4x | E29.8% | n/a | ||
600867 | CN¥8.34 | -1.8% | 5.3% | CN¥16.2b | CN¥9.95 | PE40x | E29.7% | 3.0% | ||
4974 | JP¥912.00 | -5.4% | -11.9% | JP¥109.8b | JP¥1,223.33 | PE190.3x | E29.7% | 1.9% | ||
RXRX | US$4.87 | 1.8% | -34.3% | US$2.1b | US$6.47 | PS32.7x | E29.6% | n/a | ||
4592 | JP¥2,323.00 | -7.3% | 133.5% | JP¥168.0b | JP¥1,735.00 | PB88.3x | E29.6% | n/a | ||
688621 | CN¥71.01 | -12.5% | 126.0% | CN¥7.8b | n/a | PE57.8x | E29.6% | 0.2% | ||
688076 | CN¥42.72 | -6.4% | 5.1% | CN¥13.5b | CN¥58.57 | PE27.7x | E29.5% | 1.5% | ||
LAURUSLABS | ₹862.00 | -3.1% | 88.3% | ₹465.3b | ₹694.85 | PE91.5x | E29.5% | 0.2% | ||
MNKD | US$4.49 | 14.0% | -29.1% | US$1.4b | US$9.71 | PE42x | E29.5% | n/a | ||
NEUP | US$12.21 | 76.4% | n/a | US$19.2m | US$19.50 | PE3.9x | E29.4% | n/a |